3DCRT 0 5 0 5 B-treatment
( 6 7 6 7 O
up 7 9 7 9 O
to 10 12 10 12 O
56 13 15 13 15 B-upper_bound
Gy 16 18 16 18 I-upper_bound
) 18 19 18 19 O

4 0 1 20 21 B-lower_bound
- 1 2 21 22 O
10 2 4 22 24 B-upper_bound
weeks 5 10 25 30 I-upper_bound
prior 11 16 31 36 O
to 17 19 37 39 O
surgery 20 27 40 47 B-treatment

Age 0 3 48 51 B-age
> 4 5 52 53 O
18 6 8 54 56 B-lower_bound
years 9 14 57 62 I-lower_bound

An 0 2 63 65 O
IRE 3 6 66 69 B-treatment
candidate 7 16 70 79 O
( 17 18 80 81 O
IRE 18 21 81 84 O
is 22 24 85 87 O
Percutaneous 25 37 88 100 B-treatment
irreversible 38 50 101 113 I-treatment
electroporation 51 66 114 129 I-treatment
) 66 67 129 130 O

Any 0 3 131 134 O
other 4 9 135 140 O
invasive 10 18 141 149 B-cancer
cancer 19 25 150 156 I-cancer
in 26 28 157 159 O
the 29 32 160 163 O
past 33 37 164 168 B-upper_bound
5 38 39 169 170 I-upper_bound
years 40 45 171 176 I-upper_bound
, 45 46 176 177 O
except 47 53 178 184 O
basal 54 59 185 190 B-cancer
cell 60 64 191 195 I-cancer
or 65 67 196 198 O
squamous 68 76 199 207 B-cancer
cell 77 81 208 212 I-cancer
skin 82 86 213 217 I-cancer
cancer 87 93 218 224 I-cancer

Chemotherapy 0 12 225 237 B-treatment
was 13 16 238 241 O
administered 17 29 242 254 O
for 30 33 255 258 O
2 34 35 259 260 B-lower_bound
- 35 36 260 261 O
6 36 37 261 262 B-upper_bound
cycles 38 44 263 269 O
with 45 49 270 274 O
any 50 53 275 278 O
combination 54 65 279 290 O

FOLFIRINOX 0 10 291 301 B-treatment

Gemcitabine 0 11 302 313 B-treatment
+ 12 13 314 315 O
nb 14 16 316 318 B-treatment
- 16 17 318 319 I-treatment
paclitaxel 17 27 319 329 I-treatment

No 0 2 330 332 O
prior 3 8 333 338 O
radiation 9 18 339 348 B-treatment
therapy 19 26 349 356 I-treatment
to 27 29 357 359 O
the 30 33 360 363 O
region 34 40 364 370 O
for 41 44 371 374 O
separate 45 53 375 383 O
cancer 54 60 384 390 B-cancer

Participant 0 11 391 402 O
in 12 14 403 405 O
other 15 20 406 411 B-treatment
clinical 21 29 412 420 I-treatment
trials 30 36 421 427 I-treatment

Patient 0 7 428 435 O
Received 8 16 436 444 O
neoadjuvant 17 28 445 456 B-treatment
chemoradiation 29 43 457 471 I-treatment

Patient 0 7 472 479 O
does 8 12 480 484 O
not 13 16 485 488 O
have 17 21 489 493 O
metastatic 22 32 494 504 B-cancer
disease 33 40 505 512 I-cancer

Patient 0 7 513 520 O
selected 8 16 521 529 O
to 17 19 530 532 O
undergo 20 27 533 540 O
Whipple 28 35 541 548 B-treatment
procedure 36 45 549 558 I-treatment
or 46 48 559 561 O
distal 49 55 562 568 B-treatment
pancreatectomy 56 70 569 583 I-treatment

locally 0 7 584 591 O
advanced 8 16 592 600 O
pancreatic 17 27 601 611 B-cancer
adenocarcinoma 28 42 612 626 I-cancer

with 0 4 627 631 O
concurrent 5 15 632 642 O
gemcitabine 16 27 643 654 B-treatment
, 27 28 654 655 O
capecitabine 29 41 656 668 B-treatment
, 41 42 668 669 O
or 43 45 670 672 O
infusional 46 56 673 683 B-treatment
5 57 58 684 685 I-treatment
- 58 59 685 686 I-treatment
fluorouracil 59 71 686 698 I-treatment

